Personalized Treatment of Urogenital Cancers Depends on the Microbiome

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Microbial Disease

In brief

This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.

Key facts

Study ID

NCT03962920

Run by

Zealand University Hospital

People needed

28

Starts

2020-05-01

Expected to finish

2027-05-01

Last updated by the study team

2024-01-30

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy verified diagnosis of urological cancer, localized disease

You may not qualify if…

• Hospitalization within three months of surgery
• Antibiotics within three months of surgery
• Infectious disease, including UTI's within three months of surgery
• History of cancers of the genitourinary tract
• Diabetes

Where it is running

• Zealand University Hospital — Roskilde, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.